Evidence map›Paper›PMID 40833659›Full record

ArticleJournal of autism and developmental disorders2025

Psychometric Properties of Measuring Tools for Depression in Autistic Youths: A Systematic Review.

Héloïse Young, Hélène Lahaye, Jean-Marc Guilé, Cora Cravero, Angèle Consoli, David Cohen, Real Labelle, Xavier Benarous

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of autism and developmental disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Héloïse YoungDepartment of Child and Adolescent Psychopathology, Rouen University Hospital, Rouen, France.
Hélène LahayeDepartment of Child and Adolescent Psychopathology, Amiens University Hospital, Amiens, France.
Jean-Marc GuiléDepartment of Child and Adolescent Psychopathology, Amiens University Hospital, Amiens, France.
Cora CraveroDepartment of Child and Adolescent Psychiatry, Pitié-Salpêtrière University Hospital, APHP.Sorbonne Université, 83 boulevard de l'Hôpital, 75013, Paris, France.
Angèle ConsoliDepartment of Child and Adolescent Psychiatry, Pitié-Salpêtrière University Hospital, APHP.Sorbonne Université, 83 boulevard de l'Hôpital, 75013, Paris, France.
David CohenDepartment of Child and Adolescent Psychiatry, Pitié-Salpêtrière University Hospital, APHP.Sorbonne Université, 83 boulevard de l'Hôpital, 75013, Paris, France.
Real LabelleDepartment of Psychology, Université du Québec à Montréal, Montréal, Québec, Canada.
Xavier BenarousDepartment of Child and Adolescent Psychiatry, Pitié-Salpêtrière University Hospital, APHP.Sorbonne Université, 83 boulevard de l'Hôpital, 75013, Paris, France. xavier.benarous@aphp.fr.ORCID http://orcid.org/0000-0003-1994-5779

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While autistic individuals are 4 times more likely to have depression compared to non-autistic individuals, depression remained largely undetected in this group resulting in significant unmet needs. A systematic literature review was conducted to determine the psychometric properties of measuring tools for depressive symptoms in autistic children and adolescents. The review followed the PRISMA 2020 guideline (PROSPERO: CRD42023423377) based on the search of several databases from 1980 until November 2024. The COnsensus-based Standards for the Selection of health status Measurement INstruments (COSMIN) checklist was used to assess for each tool: internal consistency, reliability, measurement error, content validity, structural validity, hypothesis testing, criterion validity, responsiveness to change and cross-cultural validity. The review found 15 empirical studies evaluating the properties of twelve measuring tools for depression in autistic youths. The validities of standards screening scales were low, but better for questionnaires with items focusing on behavioral aspects of depression, i.e., the Patient Health Questionnaire-9 (PHQ-9) and the Hospital Anxiety and Depression Scale (HADS). The evidence supporting the quality of the instrument was much better for those developed for subjects with neurodevelopmental divergences, such as The Evaluation of Depressive symptoms in Autism (EDA), with five domains of psychometric properties rated as strong or moderate. To determine the optimal approach for the use of consensual instruments, further research should include more individuals with co-occurring neurodevelopmental conditions, a risk factor for a more resistant form of depression, and examine the instruments' capacity to detect clinically significant changes during an intervention.

Indexed as

IrritabilityMeasuring instrumentMood disordersNeurodevelopmental disordersOutcome

Identifiers

PMID40833659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.